Jon A. Buras

4.2k total citations · 1 hit paper
33 papers, 3.4k citations indexed

About

Jon A. Buras is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Jon A. Buras has authored 33 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Jon A. Buras's work include Complement system in diseases (8 papers), Immune Response and Inflammation (7 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Jon A. Buras is often cited by papers focused on Complement system in diseases (8 papers), Immune Response and Inflammation (7 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Jon A. Buras collaborates with scholars based in United States, Switzerland and Canada. Jon A. Buras's co-authors include Michail V. Sitkovsky, Bernhard Holzmann, Gregory L. Stahl, Wende R. Reenstra, Charles D. Collard, Matthew J. Fenton, Raymond P. Donnelly, Michael Montalto, Bryan Belikoff and Azin Agah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Jon A. Buras

33 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Animal Models of sepsis: setting the stage

2005 680 citations Jon A. Buras, Bernhard Holzmann et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Jon A. Buras

Since Specialization

Citations

This map shows the geographic impact of Jon A. Buras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon A. Buras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon A. Buras more than expected).

Fields of papers citing papers by Jon A. Buras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon A. Buras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon A. Buras. The network helps show where Jon A. Buras may publish in the future.

Co-authorship network of co-authors of Jon A. Buras

This figure shows the co-authorship network connecting the top 25 collaborators of Jon A. Buras. A scholar is included among the top collaborators of Jon A. Buras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon A. Buras. Jon A. Buras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endothelial–neutrophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen 2007 ·Neurological Research ·Jon A. Buras, Wende R. Reenstra	49
2	Hyperbaric Oxygen Reduces Acetaminophen Toxicity and Increases HIF‐1α Expression 2006 ·Academic Emergency Medicine ·Steven D. Salhanick, Bryan Belikoff, (unknown), Douglas E. Holt, Wende R. Reenstra, Jon A. Buras	34
3	Endothelially Derived Nitric Oxide Affects the Severity of Early Acetaminophen‐induced Hepatic Injury in Mice 2006 ·Academic Emergency Medicine ·Steven D. Salhanick, (unknown), (unknown), (unknown), Wende R. Reenstra, Jon A. Buras	10
4	Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality 2006 ·The Journal of Experimental Medicine ·Kiichiro Yano, Patricia C. Liaw, Janet Mullington, Shu‐Ching Shih, Hitomi Okada, Natalya D. Bodyak, Peter Kang, Lisa J. Toltl, Bryan Belikoff, Jon A. Buras, B. T. Simms, Joseph P. Mizgerd, Peter Carmeliet, S. Ananth Karumanchi, William C. Aird	223
5	Hyperbaric oxygen protects from sepsis mortality via an interleukin-10–dependent mechanism* 2006 ·Critical Care Medicine ·Jon A. Buras, Douglas E. Holt, (unknown), Bryan Belikoff, (unknown), Wende R. Reenstra	63
6	Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol* 2006 ·Critical Care Medicine ·Nathan I. Shapiro, Michael D. Howell, Daniel Talmor, (unknown), Long Ngo, Jon A. Buras, Richard E. Wolfe, J. Woodrow Weiss, Alan Lisbon	271
7	CpG Oligodeoxynucleotide Protection in Polymicrobial Sepsis Is Dependent on Interleukin‐17 2005 ·The Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Gregory L. Stahl, (unknown), Hiromi Wada, William C. Aird, Jon A. Buras	34
8	Bilateral Acetabular Fractures Associated With a Seizure: A Case Report 2005 ·Annals of Emergency Medicine ·(unknown), Jon A. Buras	29
9	Troglitazone‐Induced Changes in Adiponectin Do Not Affect Endothelial Function in Diabetes 2005 ·Obesity Research ·Jon A. Buras, Wende R. Reenstra, (unknown), Edward S. Horton, Aristidis Veves	8
10	Animal Models of sepsis: setting the stage breakdown → 2005 ·Nature Reviews Drug Discovery ·Jon A. Buras, Bernhard Holzmann, Michail V. Sitkovsky	680
11	Inhibition of C5 or absence of C6 protects from sepsis mortality 2004 ·Immunobiology ·Jon A. Buras, (unknown), (unknown), (unknown), Wende R. Reenstra, (unknown), Gregory L. Stahl	27
12	Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury 2003 ·American Journal Of Pathology ·Gregory L. Stahl, Yuanyuan Xu, Liming Hao, Mendy Miller, Jon A. Buras, Michael Fung, Hui Zhao	142
13	Anoxia and reoxygenation of human endothelial cells decreases ceramide glucosyltransferase expression and activates caspases 2003 ·The FASEB Journal ·Hui Zhao, Mendy Miller, (unknown), Jon A. Buras, Gregory L. Stahl	17
14	Endothelial Oxidative Stress Activates the Lectin Complement Pathway 2001 ·American Journal Of Pathology ·Charles D. Collard, Michael Montalto, Wende R. Reenstra, Jon A. Buras, Gregory L. Stahl	115
15	A Keratin Peptide Inhibits Mannose-Binding Lectin 2001 ·The Journal of Immunology ·Michael Montalto, Charles D. Collard, Jon A. Buras, Wende R. Reenstra, Rebecca J. McClaine, David R. Gies, Russell P. Rother, Gregory L. Stahl	35
16	Basic Mechanisms of Hyperbaric Oxygen in the Treatment of Ischemia-Reperfusion Injury 2000 ·International Anesthesiology Clinics ·Jon A. Buras	105
17	Complement Activation after Oxidative Stress 2000 ·American Journal Of Pathology ·Charles D. Collard, Antti Väkevä, (unknown), Azin Agah, Scott A. Rollins, Wende R. Reenstra, Jon A. Buras, Seppo Meri, Gregory L. Stahl	284
18	Endothelial Nuclear Factor-κB Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Charles D. Collard, Azin Agah, Wende R. Reenstra, Jon A. Buras, Gregory L. Stahl	43
19	NFβA, a factor required for maximal interleukin-1β gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation 1995 ·Molecular Immunology ·Jon A. Buras, Wende R. Reenstra, Matthew J. Fenton	34
20	An upstream protein interacts with a distinct protein that binds to the cap site of the human interleukin 1β gene 1994 ·Molecular Immunology ·Brian G. Monks, Bridget Martell, Jon A. Buras, Matthew J. Fenton	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact